PCSK9 Inhibitors and Cardiovascular Events
- PMID: 26295078
- DOI: 10.1056/NEJMc1508222
PCSK9 Inhibitors and Cardiovascular Events
Comment on
-
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.N Engl J Med. 2015 Apr 16;372(16):1500-9. doi: 10.1056/NEJMoa1500858. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773607 Clinical Trial.
-
PCSK9 Inhibitors and Cardiovascular Events.N Engl J Med. 2015 Aug 20;373(8):773-4. doi: 10.1056/NEJMc1508222. N Engl J Med. 2015. PMID: 26287856 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous